瓦克赛特生物 PCVX
$63.89 +$1.97 (+3.18%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $64.05 +0.25%
开盘$61.92
昨收$61.92
当日区间$61.14 – $65.30
成交量1.84M
市值$10.11B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$302.78M-33.8% YoY
净利润-$284.30M-70.7% YoY
摊薄每股收益-$1.97-61.5% YoY
自由现金流-$237.05M-81.1% YoY
经营现金流-$232.47M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-36.5%
资产收益率-33.0%
投入资本回报率-38.9%
流动比率5.72
负债/资产比率12.1%
现金及投资$1.49B
总负债$108.94M
净现金（净负债）$1.38B
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $302.78M | $345.85M | $923.68M | $274.28M | $242.38M |
| 销售及管理费用 | $34.93M | $33.07M | $129.37M | $32.22M | $32.45M |
| -管理费用 | $34.93M | $33.07M | $129.37M | $32.22M | $32.45M |
| 研发费用 | $267.85M | $312.78M | $794.31M | $242.06M | $209.93M |
| 营业利润 | -$302.78M | -$345.85M | -$923.68M | -$274.28M | -$242.38M |
| 非经营性利息净收入（支出） | $25.76M | $26.61M | $119.72M | $26.45M | $29.26M |
| 非经营性利息收入 | $25.76M | $26.61M | $119.72M | $26.45M | $29.26M |
| 其他收入（支出） | -$7.28M | -$1.38M | $37.33M | $1.33M | $291,000.00 |
| 其他非经营性收入（支出） | -$7.28M | -$1.38M | $37.33M | $1.33M | $291,000.00 |
| 税前利润 | -$284.30M | -$320.62M | -$766.63M | -$246.51M | -$212.83M |
| 净利润 | -$284.30M | -$320.62M | -$766.63M | -$246.51M | -$212.83M |
| 持续经营利润 | -$284.30M | -$320.62M | -$766.63M | -$246.51M | -$212.83M |
| 归属母公司净利润 | -$284.30M | -$320.62M | -$766.63M | -$246.51M | -$212.83M |
| 归属普通股股东净利润 | -$284.30M | -$320.62M | -$766.63M | -$246.51M | -$212.83M |
| 基本每股收益 | -$1.97 | -$2.30 | -$5.63 | -$1.80 | -$1.56 |
| 摊薄每股收益 | -$1.97 | -$2.30 | -$5.63 | -$1.80 | -$1.56 |
| 特殊收益（费用） | – | – | $0.00 | – | – |
| -减：重组及并购费用 | – | – | $0.00 | – | – |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $3.14B | $3.35B | $3.00B | $3.00B | $3.17B |
| 流动资产合计 | $1.55B | $1.81B | $1.63B | $1.63B | $1.77B |
| 现金及现金等价物与短期投资 | $1.49B | $1.74B | $1.56B | $1.56B | $1.71B |
| -现金及现金等价物 | $183.19M | $260.84M | $173.96M | $173.96M | $281.08M |
| -短期投资 | $1.30B | $1.48B | $1.39B | $1.39B | $1.43B |
| 其他流动资产 | $65.83M | $76.31M | $66.40M | $66.40M | $55.85M |
| 非流动资产合计 | $1.59B | $1.53B | $1.38B | $1.38B | $1.40B |
| 固定资产净值 | $370.57M | $373.80M | $491.72M | $491.72M | $337.00M |
| -固定资产原值 | $370.57M | $373.80M | $524.49M | $524.49M | $337.00M |
| 投资及预付款 | $1.02B | $1.00B | $881.66M | $881.66M | $959.26M |
| 其他非流动资产 | $194.02M | $157.01M | $1.97M | $1.97M | $108.18M |
| 负债合计 | $380.21M | $352.29M | $317.21M | $317.21M | $278.72M |
| 流动负债合计 | $271.28M | $242.08M | $205.75M | $205.75M | $200.05M |
| 应付款 | $100.92M | $63.06M | $75.61M | $75.61M | $48.96M |
| -应付账款 | $100.92M | $63.06M | $70.90M | $70.90M | $48.96M |
| 一年内应计费用 | $150.03M | $164.95M | $101.02M | $101.02M | $128.55M |
| 短期债务及融资租赁负债 | $6.51M | $6.09M | $6.12M | $6.12M | $5.77M |
| -一年内到期融资租赁负债 | $6.51M | $6.09M | $6.12M | $6.12M | $5.77M |
| 非流动负债合计 | $108.94M | $110.21M | $111.46M | $111.46M | $78.67M |
| 长期债务及融资租赁负债 | $108.94M | $110.21M | $111.36M | $111.36M | $78.67M |
| -长期融资租赁负债 | $108.94M | $110.21M | $111.36M | $111.36M | $78.67M |
| 股东权益合计 | $2.76B | $3.00B | $2.69B | $2.69B | $2.89B |
| 股东权益 | $2.76B | $3.00B | $2.69B | $2.69B | $2.89B |
| 股本 | $148,000.00 | $147,000.00 | $134,000.00 | $134,000.00 | $133,000.00 |
| -普通股 | $148,000.00 | $147,000.00 | $134,000.00 | $134,000.00 | $133,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $5.53B | $5.48B | $4.84B | $4.84B | $4.80B |
| 留存收益 | -$2.76B | -$2.48B | -$2.15B | -$2.15B | -$1.91B |
| 不影响留存收益的损益 | -$7.55M | -$6.83M | $1.59M | $1.59M | $856,000.00 |
| -累计折旧 | – | – | -$32.77M | -$32.77M | – |
| -可供出售证券 | – | – | $881.66M | $881.66M | – |
| -应付税款合计 | – | – | $4.71M | $4.71M | – |
| 其他非流动负债 | – | – | $100,000.00 | $100,000.00 | – |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$232.47M | -$280.63M | -$655.58M | -$224.83M | -$143.31M |
| 持续经营经营活动现金流净额 | -$232.47M | -$280.63M | -$655.58M | -$224.83M | -$143.31M |
| 持续经营净利润 | -$284.30M | -$320.62M | -$766.63M | -$246.51M | -$212.83M |
| 持续经营损益 | $5.17M | $2.20M | -$34.77M | -$1.66M | -$789,000.00 |
| 折旧、折耗与摊销 | $5.93M | $5.85M | $24.86M | $9.80M | $5.20M |
| 营运资金变动 | $673,000.00 | -$2.91M | -$3.45M | -$19.70M | $32.08M |
| -预付资产变动 | $13.67M | -$8.74M | -$16.80M | -$9.55M | $915,000.00 |
| -应付账款及应计费用变动 | $34.94M | $39.01M | $56.93M | -$3.18M | $37.93M |
| -其他流动资产变动 | -$52.95M | -$16.88M | -$92.26M | -$46.34M | -$11.32M |
| -其他流动负债变动 | -$851,000.00 | -$1.29M | $46.37M | $33.14M | -$1.40M |
| -其他营运资金变动 | $5.87M | -$15.02M | $2.30M | $6.23M | $5.95M |
| 投资活动现金流净额 | $147.72M | -$233.41M | $437.35M | $115.13M | $121.17M |
| 持续经营投资活动现金流净额 | $147.72M | -$233.41M | $437.35M | $115.13M | $121.17M |
| 固定资产购置及出售净额 | -$4.57M | -$14.79M | -$56.97M | -$8.42M | -$12.05M |
| 投资购置及出售净额 | $152.29M | -$218.62M | $494.33M | $123.55M | $133.22M |
| 筹资活动现金流 | $5.70M | $601.58M | $2.01M | $2.41M | -$3.67M |
| 持续经营筹资活动现金流净额 | $5.70M | $601.58M | $2.01M | $2.41M | -$3.67M |
| 普通股发行净额 | $0.00 | $601.85M | $0.00 | $0.00 | $0.00 |
| 股票期权行使所得 | $7.76M | $9.03M | $13.01M | $3.42M | $306,000.00 |
| 其他筹资费用净额 | -$2.06M | -$9.30M | -$10.99M | -$1.01M | -$3.98M |
| 期末现金余额 | $184.66M | $262.31M | $175.43M | $175.43M | $282.55M |
| 现金净变动 | -$79.05M | $87.55M | -$216.21M | -$107.30M | -$25.81M |
| 期初现金余额 | $262.31M | $175.43M | $389.20M | $282.55M | $308.06M |
| 汇率变动影响 | $1.40M | -$664,000.00 | $2.44M | $176,000.00 | $291,000.00 |
| 自由现金流 | -$237.05M | -$295.42M | -$712.55M | -$233.25M | -$155.35M |
| 其他非现金项目 | – | – | -$14.43M | -$2.76M | -$2.26M |
暂无评论——快来第一个聊聊 PCVX。
登录后参与讨论。